Drug Type Small molecule drug |
Synonyms |
Action inhibitors, antagonists |
Mechanism CRAF inhibitors(C-Raf kinase inhibitors), SRC inhibitors(Tyrosine-protein kinase SRC inhibitors), VEGFR2 antagonists(Vascular endothelial growth factor receptor 2 antagonists) + [1] |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Choroidal Neovascularization | Preclinical | United States | 01 Apr 2011 | |
Dystrophy, Macular | Preclinical | United States | - |